title: Estrogen receptor alpha polymorphisms and the risk of malignancies.
abstract: Estrogens represent risk factors for endocrine-related cancers and play also an important role in the development and progression of other malignancies. In order to analyze the associations between estrogen receptor gene alpha polymorphisms and cancers susceptibility, we genotyped six single nucleotide polymorphisms (SNPs) in 163 Caucasian cancer patients--103 breast cancers and 60 other malignancies (colorectal, bladder, hepatocellular carcinoma and acute myeloid leukemia)--and 114 healthy controls using hybridization probes. We performed Armitage`s association trend-test to evaluate the risk. Linkage disequilibrium (LD) was assessed for each pair of markers. The genotypes CC and CT of rs3798577 were significantly associated with the cancers risk (p-trend breast = 4 × 10(-5); p-trend cancers = 1 × 10(-5)); in discrepancy with breast cancer where the C-allele represented the risk allele, for bladder, hepatocellular carcinomas and leukemia, the T allele seems to confer susceptibility. The minor G allele of rs1801132 was protective in our cases (p = 1 × 10(-4)); for rs2228480, the heterozygous frequency was higher for cancer groups (p = 0.03); the SNP pairs rs2228480&rs3798577 and rs2234693&rs9340799 were in low LD; the haplotypes T-A of rs2234693&rs9340799 and G-C of rs2228480&rs3798577 showed a trend to be higher represented in breast cancers; T allele of rs2234693 was higher expressed in breast, colon cancers and leukemia; rs2077647 was associated with colon (p = 0.008, C-risk allele) and bladder (p = 0.01, T-risk allele) cancers. We concluded that ESR1 polymorphisms may have distinct impact in carcinogenesis and further genotyping will establish whether these findings remain significant in larger cohorts.
authors.affiliation: Biochemistry Department, University of Medicine and Pharmacy Victor Babes Timisoara, Eftimie Murgu 2A, Timisoara 300041, Romania.
authors.forename: Andrei
authors.initials: A
authors.lastname: Anghel
authors.forename: Diana
authors.initials: D
authors.lastname: Narita
authors.forename: Edward
authors.initials: E
authors.lastname: Seclaman
authors.forename: Emilian
authors.initials: E
authors.lastname: Popovici
authors.forename: Mariana
authors.initials: M
authors.lastname: Anghel
authors.forename: Liviu
authors.initials: L
authors.lastname: Tamas
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics; D016022:Case-Control Studies; D047628:Estrogen Receptor alpha / Q000235:genetics*; D005260:Female; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D009369:Neoplasms / Q000235:genetics*; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors
chemical_list: D047628:Estrogen Receptor alpha
references.citation: Cancer Lett. 2001 Jul 10;168(1):65-70
references.pmid: 11368879
references.citation: Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4340-5
references.pmid: 18326623
references.citation: Gastroenterology. 2006 Jun;130(7):2001-9
references.pmid: 16762623
references.citation: Cancer Res. 2000 Jan 15;60(2):245-8
references.pmid: 10667568
references.citation: Nat Struct Mol Biol. 2008 Aug;15(8):819-26
references.pmid: 18641664
references.citation: Steroids. 2002 Sep;67(10):815-9
references.pmid: 12231116
references.citation: BMC Med Genet. 2007 Dec 04;8:73
references.pmid: 18053221
references.citation: Hepatology. 2004 Aug;40(2):318-26
references.pmid: 15368436
references.citation: Mol Cell Biol. 2008 Jan;28(2):883-95
references.pmid: 18025108
references.citation: Cancer Res. 1982 Nov;42(11):4701-5
references.pmid: 6957260
references.citation: Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W621-5
references.pmid: 16845085
references.citation: Breast Cancer. 1997 Jul 31;4(2):57-66
references.pmid: 11091579
references.citation: Folia Histochem Cytobiol. 2007;45(4):331-8
references.pmid: 18165171
references.citation: Breast Cancer Res. 2004;6(3):R180-6
references.pmid: 15084241
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2936-42
references.pmid: 16365013
references.citation: PLoS Genet. 2007 Mar 16;3(3):e42
references.pmid: 17367212
references.citation: Breast Cancer Res. 2008;10(6):R108
references.pmid: 19094228
references.citation: Hum Genet. 1994 Dec;94(6):665-70
references.pmid: 7989041
references.citation: Cancer Lett. 2009 Dec 1;286(1):89-95
references.pmid: 19144459
references.citation: Breast Cancer Res. 2004;6(4):R437-49
references.pmid: 15217512
references.citation: Eur J Hum Genet. 2009 Jun;17(6):722-31
references.pmid: 19092773
references.citation: Breast Cancer Res Treat. 2007 Dec;106(2):273-80
references.pmid: 17268813
references.citation: N Engl J Med. 2002 Mar 28;346(13):967-74
references.pmid: 11919305
references.citation: J Biol Chem. 2006 Apr 14;281(15):9837-40
references.pmid: 16469747
references.citation: Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):843-54
references.pmid: 10548311
references.citation: Clin Cancer Res. 2005 Feb 1;11(3):1093-8
references.pmid: 15709176
references.citation: Mol Cell Endocrinol. 2008 Nov 25;295(1-2):94-100
references.pmid: 18762230
references.citation: Cancer Res. 2004 Nov 1;64(21):7647-54
references.pmid: 15520162
references.citation: J Clin Invest. 2006 Mar;116(3):561-70
references.pmid: 16511588
references.citation: Nature. 2007 Jun 28;447(7148):1087-93
references.pmid: 17529967
references.citation: J Natl Cancer Inst. 1995 Mar 15;87(6):446-51
references.pmid: 7861463
references.citation: Breast Cancer Res. 2007;9(2):R27
references.pmid: 17428325
references.citation: BMC Bioinformatics. 2007 Nov 02;8:428
references.pmid: 17980034
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):853-9
references.pmid: 14504194
references.citation: Int J Colorectal Dis. 2007 Apr;22(4):395-400
references.pmid: 16788818
references.citation: N Engl J Med. 2008 Jun 26;358(26):2796-803
references.pmid: 18579814
references.citation: Cancer Res. 1992 Jan 1;52(1):77-83
references.pmid: 1345763
references.citation: Breast Cancer Res Treat. 2008 Feb;107(3):415-9
references.pmid: 17453340
references.citation: Breast Cancer Res Treat. 2003 Jul;80(1):127-31
references.pmid: 12889606
references.citation: Breast Cancer Res. 2008;10(1):R15
references.pmid: 18271972
references.citation: BMC Genet. 2004 May 24;5:11
references.pmid: 15157284
references.citation: Breast J. 2002 Jul-Aug;8(4):226-9
references.pmid: 12100115
references.citation: Mol Cell Endocrinol. 2003 Apr 28;202(1-2):109-16
references.pmid: 12770739
references.citation: Int J Cancer. 1997 Dec 19;74(6):664-9
references.pmid: 9421366
references.citation: Endocr Relat Cancer. 2008 Mar;15(1):351-64
references.pmid: 18310301
references.citation: PLoS One. 2008 Jun 30;3(7):e2816
references.pmid: 18636124
references.citation: Eur J Cancer. 2001 Aug;37(12):1463-8
references.pmid: 11506951
references.citation: J Natl Cancer Inst. 1998 Apr 1;90(7):532-6
references.pmid: 9539249
references.citation: Genes Cells. 2008 Jul;13(7):723-30
references.pmid: 18498351
references.citation: Nature. 2007 Oct 18;449(7164):851-61
references.pmid: 17943122
references.citation: Cancer Res. 2004 Dec 15;64(24):8891-900
references.pmid: 15604249
references.citation: Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W635-41
references.pmid: 16845089
references.citation: J Med Genet. 2005 Oct;42(10):796-800
references.pmid: 16199553
references.citation: Leuk Res. 1991;15(5):315-20
references.pmid: 2046384
references.citation: Am J Epidemiol. 2005 Feb 15;161(4):307-20
references.pmid: 15692074
references.citation: BMC Cancer. 2006 Jun 29;6:173
references.pmid: 16808847
references.citation: Cancer Causes Control. 2005 Dec;16(10):1195-202
references.pmid: 16215870